Alembic’s subsidiary, Aleor Dermaceuticals, has received the Food and Drug Administration’s approval for diclofenac sodium topical gel 3%, a generic of Fougera’s Solaraze topical gel.
[Read more: Alembic intros generic Perforomist]
The medication is indicated for the topical treatment of actinic keratoses, and sun avoidance is indicated during therapy.
Diclofenac sodium topical gel had a market value of roughly $10 million for the 12 months ending March 2022, according to IQVIA.
[Read more: Alembic obtains FDA nod for 2 generics]